Evidence map›Paper›PMID 37693278›Full record

ArticleBiocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al2023

Effect of non-enzymatic glycation on collagen nanoscale mechanisms in diabetic and age-related bone fragility.

James L Rosenberg, William Woolley, Ihsan Elnunu, Julia Kamml, David S Kammer, Claire Acevedo

Open access · diamondAbstract read
In one paragraph

Article in Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Pentosidine as a biomarker for bone fragility: Molecular mechanisms, clinical relevance, and detection strategies.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2026
    Review
  4. The Impact of Ageing on Fibrillar Collagens.Sub-cellular biochemistry · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

James L RosenbergDepartment of Mechanical Engineering, University of Utah, Salt Lake City, 84112, USA.
William WoolleyDepartment of Mechanical Engineering, University of Utah, Salt Lake City, 84112, USA.
Ihsan ElnunuDepartment of Mechanical Engineering, University of Utah, Salt Lake City, 84112, USA.
Julia KammlInstitute for Building Materials, ETH Zurich, Zurich, Switzerland.
David S KammerInstitute for Building Materials, ETH Zurich, Zurich, Switzerland.
Claire AcevedoDepartment of Mechanical Engineering, University of Utah, Salt Lake City, 84112, USA.
University of Utah · USETH Zurich · CH

Funding

Quantifying the contribution of collagen cross-linking to increased bone fragilityR21AR077881 · NIAMS · UNIVERSITY OF UTAH · PI ACEVEDO, CLAIRE, KAMMER, DAVID · 2021 to 2022
$324k
NIAMS NIH HHS R21 AR077881
6 · The paper itself

Abstract

Age and diabetes have long been known to induce an oxidative reaction between glucose and collagen, leading to the accumulation of advanced glycation end-products (AGEs) cross-links in collagenous tissues. More recently, AGEs content has been related to loss of bone quality, independent of bone mass, and increased fracture risk with aging and diabetes. Loss of bone quality is mostly attributed to changes in material properties, structural organization, or cellular remodeling. Though all these factors play a role in bone fragility disease, some common recurring patterns can be found between diabetic and age-related bone fragility. The main pattern we will discuss in this viewpoint is the increase of fibrillar collagen stiffness and loss of collagen-induced plasticity with AGE accumulation. This study focused on recent related experimental studies and discusses the correlation between fluorescent AGEs content at the molecular and fibrillar scales, collagen deformation mechanisms at the nanoscale, and resistance to bone fracture at the macroscale.

Indexed as

Advanced glycation end-productsAgingBone fragilityCollagenDiabetes

Identifiers

PMID37693278
PMCPMC10486207
OpenAlexW4381988122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.